← 홈

Antibody · IL-4R

22개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-13 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 22개
AntibodyAHOTFDACuratedFDABiologicSanofiApproved

dupilumab (Dupixent)

Atopic dermatitis, asthma, CRSwNP, EoE · IL-4Rα

#IL-4R#Antibody#Approved#FDA승인#바이오모아추천+5
효능 ORR 0.45%임상시험 216상태 APPROVED
AntibodyCSanofiPhase 3

REGN668 (Dupilumab SAR231893, Dupilumab SAR231893 (REGN668))

Prurigo Nodularis · Dermatitis Atopic

#DermatitisAtopic#Antibody#Phase3#인기#항체+5
효능 ORR 0.45%임상시험 70상태 ACTIVE
AntibodySanofiApproved

Dupilumab SAR231893 (Dupilumab SAR231893)

Chronic Obstructive Pulmonary Disease · Dermatitis Atopic

#DermatitisAtopic#Antibody#Approved#인기#항체+5
효능 ORR 0.44%임상시험 57상태 ACTIVE
AntibodystaleSanofiApproved

Dupilumab Prefilled Syringe (Dupilumab Prefilled Syringe)

Netherton Syndrome · Netherton Syndrome

#NethertonSyndrome#Antibody#Approved#항체#면역항체+2
임상시험 15상태 RECRUITING
AntibodystaleSanofiPreclinical

Dupilumab - Standard Dose (Dupilumab - Standard Dose)

Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP); Smell Loss · Atopic Dermatitis

#AtopicDermatitis#Antibody#Preclinical#항체#면역항체+4
임상시험 10상태 RECRUITING
AntibodystaleSanofiPreclinical

dupilumab, mepolizumab and benralizumab according to their marketing approval (Biologic treatments available in CRSwNP, Biologic treatments available in CRSwNP (dupilumab, mepolizumab and benralizumab according to their marketing approval))

Chronic Rhinosinusitis With Nasal Polyps · Chronic Rhinosinusitis With Nasal Polyps

#ChronicRhinosinusitisWithNasalPo#Antibody#Preclinical#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiPhase 1

dupilumab (DUPIXENT®, DUPIXENT® (dupilumab))

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiPhase 2

blinded (Dupilumab, Dupilumab (blinded))

Eosinophilic Gastritis; Eosinophilic Gastroenteritis · Eosinophilic Gastritis

#EosinophilicGastritis#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleSanofiApproved

Dupilumab - Discontinuation (Dupilumab - Discontinuation)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiApproved

Dupilumab - Dose Reduction (Dupilumab - Dose Reduction)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiApproved

Dupilumab Only Product (Dupilumab Only Product)

Atopic Dermatitis; AD · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 1

Dupilumab coformulated with berahyaluronidase alfa (Dupilumab coformulated with berahyaluronidase alfa)

Healthy Volunteers · Healthy Volunteers

#HealthyVolunteers#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiPhase 1

Dupilumab for MAD (Dupilumab for MAD)

Healthy Participants; Atopic Dermatitis Patients · Healthy Participants

#HealthyParticipants#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 2

Dupilumab open label extension phase (Dupilumab open label extension phase)

Nephrotic Syndrome in Children; Nephrotic Syndrome Steroid-Dependent · Nephrotic Syndrome in Children

#NephroticSyndromeinChildren#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleSanofiApproved

Dupilumab step-down (Dupilumab step-down)

Atopic Dermatitis; Eczema, Atopic · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleSanofiApproved

Dupilumab therapy (Dupilumab therapy)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Approved#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 3

Dupilumab/Dupixent (Dupilumab/Dupixent)

Asthma · Asthma

#Asthma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleSanofiPhase 2

REGN3500 + Dupilumab Combo (REGN3500 + Dupilumab Combo)

Atopic Dermatitis · Atopic Dermatitis

#AtopicDermatitis#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleSanofiApproved

Stopping dupilumab (Stopping dupilumab)

Severe Asthma · Severe Asthma

#SevereAsthma#Antibody#Approved#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleSanofiPreclinical

Systemic dupilumab (Systemic dupilumab)

Dermatitis, Atopic · Dermatitis, Atopic

#DermatitisAtopic#Antibody#Preclinical#항체#면역항체+4
임상시험 1상태 ACTIVE

1 / 2 페이지

← 이전다음 →